基于诊断的医疗保险处方药计划支付风险调整。

Health Care Financing Review Pub Date : 2007-01-01
John Robst, Jesse M Levy, Melvin J Ingber
{"title":"基于诊断的医疗保险处方药计划支付风险调整。","authors":"John Robst,&nbsp;Jesse M Levy,&nbsp;Melvin J Ingber","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The 2003 Medicare Prescription Drug, Improvement, and Modernization Act (MMA) created Medicare Part D, a voluntary prescription drug benefit program. The benefit is a government subsidized prescription drug benefit within Medicare. This article focuses on the development of the prescription drug risk-adjustment model used to adjust payments to reflect the health status of plan enrollees.</p>","PeriodicalId":55071,"journal":{"name":"Health Care Financing Review","volume":"28 4","pages":"15-30"},"PeriodicalIF":0.0000,"publicationDate":"2007-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195001/pdf/","citationCount":"0","resultStr":"{\"title\":\"Diagnosis-based risk adjustment for medicare prescription drug plan payments.\",\"authors\":\"John Robst,&nbsp;Jesse M Levy,&nbsp;Melvin J Ingber\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The 2003 Medicare Prescription Drug, Improvement, and Modernization Act (MMA) created Medicare Part D, a voluntary prescription drug benefit program. The benefit is a government subsidized prescription drug benefit within Medicare. This article focuses on the development of the prescription drug risk-adjustment model used to adjust payments to reflect the health status of plan enrollees.</p>\",\"PeriodicalId\":55071,\"journal\":{\"name\":\"Health Care Financing Review\",\"volume\":\"28 4\",\"pages\":\"15-30\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2007-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195001/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Health Care Financing Review\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Health Care Financing Review","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

2003年的医疗保险处方药、改进和现代化法案(MMA)创建了医疗保险D部分,这是一个自愿的处方药福利计划。这项福利是政府在医疗保险中补贴的处方药福利。本文的重点是处方药风险调整模型的发展,用于调整支付,以反映计划参保人的健康状况。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Diagnosis-based risk adjustment for medicare prescription drug plan payments.

Diagnosis-based risk adjustment for medicare prescription drug plan payments.

The 2003 Medicare Prescription Drug, Improvement, and Modernization Act (MMA) created Medicare Part D, a voluntary prescription drug benefit program. The benefit is a government subsidized prescription drug benefit within Medicare. This article focuses on the development of the prescription drug risk-adjustment model used to adjust payments to reflect the health status of plan enrollees.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Health Care Financing Review
Health Care Financing Review 医学-卫生保健
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信